308 related articles for article (PubMed ID: 15049832)
1. The coactivator LXXLL nuclear receptor recognition motif.
Savkur RS; Burris TP
J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
[TBL] [Abstract][Full Text] [Related]
2. Recognition of LXXLL by ligand binding domain of the Farnesoid X receptor in molecular dynamics simulation.
Zhang T; Dong XC; Chen MB
J Chem Inf Model; 2006; 46(6):2623-30. PubMed ID: 17125202
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
[TBL] [Abstract][Full Text] [Related]
4. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
7. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
Bramlett KS; Wu Y; Burris TP
Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
[TBL] [Abstract][Full Text] [Related]
8. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
[TBL] [Abstract][Full Text] [Related]
9. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
Burendahl S; Treuter E; Nilsson L
Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
[TBL] [Abstract][Full Text] [Related]
12. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
Li Y; Suino K; Daugherty J; Xu HE
Mol Cell; 2005 Aug; 19(3):367-80. PubMed ID: 16061183
[TBL] [Abstract][Full Text] [Related]
13. Corepressor recruitment by agonist-bound nuclear receptors.
White JH; Fernandes I; Mader S; Yang XJ
Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
[TBL] [Abstract][Full Text] [Related]
14. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.
Ding XF; Anderson CM; Ma H; Hong H; Uht RM; Kushner PJ; Stallcup MR
Mol Endocrinol; 1998 Feb; 12(2):302-13. PubMed ID: 9482670
[TBL] [Abstract][Full Text] [Related]
15. Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactions.
Galande AK; Bramlett KS; Burris TP; Wittliff JL; Spatola AF
J Pept Res; 2004 Mar; 63(3):297-302. PubMed ID: 15049842
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the NCoA-1-STAT 6 interaction.
Seitz M; Maillard LT; Obrecht D; Robinson JA
Chembiochem; 2008 May; 9(8):1318-22. PubMed ID: 18464232
[TBL] [Abstract][Full Text] [Related]
18. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
[TBL] [Abstract][Full Text] [Related]
19. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.
Johansson L; Båvner A; Thomsen JS; Färnegårdh M; Gustafsson JA; Treuter E
Mol Cell Biol; 2000 Feb; 20(4):1124-33. PubMed ID: 10648597
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.
Ortlund EA; Lee Y; Solomon IH; Hager JM; Safi R; Choi Y; Guan Z; Tripathy A; Raetz CR; McDonnell DP; Moore DD; Redinbo MR
Nat Struct Mol Biol; 2005 Apr; 12(4):357-63. PubMed ID: 15723037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
